Skip to main content
OpenTrials

Clinical trial condition

Portal Hypertension

Explore clinical trials studying Portal Hypertension. Study availability and eligibility vary by location and protocol.

146 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Portal Hypertension trial results

Not Yet Recruiting

TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension

NCT07350070

Conditions
Digestive System Diseases, Fibrosis, HCC, +6 more
Locations
  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology Fuzhou, Fujian, China
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
  • Hubei Province Tahe Hospital Taihe, Hubei, China
  • Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Not Yet Recruiting

A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests

NCT07087041

Conditions
Alcohol-related Liver Disease, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing You'an Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
View all 28 locations
View Trial Details

Related conditions